Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
NCT03421236
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Non Muscle Invasive Bladder Cancer
Interventions
BIOLOGICAL:
Ty21a
Sponsor
Patrice Jichlinski